Nurix Therapeutics (NRIX) Insider Trading & Ownership → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free NRIX Stock Alerts $13.98 -0.18 (-1.27%) (As of 05/8/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Nurix Therapeutics (NASDAQ:NRIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$350,992.37 Get NRIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NRIX Insider Buying and Selling by Quarter Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Nurix Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/2/2024Houte Hans VanCFOSell3,499$12.83$44,892.17 4/30/2024Gwenn HansenInsiderSell2,007$12.04$24,164.28 4/30/2024Houte Hans VanCFOSell1,387$12.04$16,699.48 2/16/2024Houte Hans VanCFOSell6,812$10.02$68,256.24 1/30/2024Gwenn HansenInsiderSell2,334$7.99$18,648.66 1/30/2024Houte Hans VanCFOSell1,671$7.99$13,351.29 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/19/2023Houte Hans VanCFOSell10,906$10.00$109,060.00 10/31/2023Christine RingInsiderSell1,232$5.20$6,406.40 10/31/2023Houte Hans VanCFOSell1,080$5.20$5,616.00 7/31/2023Christine RingGeneral CounselSell1,420$9.65$13,703.00 7/31/2023Gwenn HansenInsiderSell1,884$9.65$18,180.60 7/31/2023Houte Hans VanCFOSell1,245$9.65$12,014.25 (Data available from 1/1/2013 forward) NRIX Insider Trading Activity - Frequently Asked Questions Who is on Nurix Therapeutics's Insider Roster? The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, Pierre Beaurang, and Stefani Wolff. Learn more on insiders at NRIX. What percentage of Nurix Therapeutics stock is owned by insiders? 9.80% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings. Which Nurix Therapeutics insiders have been selling company stock? The following insiders have sold NRIX shares in the last 24 months: Christine Ring ($56,997.16), Gwenn Hansen ($122,440.40), Houte Hans Van ($309,199.79), and Stefani Wolff ($18,460.20). How much insider selling is happening at Nurix Therapeutics? Insiders have sold a total of 47,925 Nurix Therapeutics shares in the last 24 months for a total of $507,097.55 sold. More Insider Trading Tools from MarketBeat Related Companies: ORIC Insider Trades WVE Insider Trades ZYME Insider Trades STOK Insider Trades MLYS Insider Trades OLMA Insider Trades IGMS Insider Trades COGT Insider Trades AVTE Insider Trades SIGA Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:NRIX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.